|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Estimated credit losses (recoveries) | |||||
| Share-based compensation | |||||
| Impairment loss | |||||
| Impairment loss on held for sale property and equipment | |||||
| Impairment loss related to goodwill and intangible assets | |||||
| Impairment loss on operating lease right-of-use assets | |||||
| Total impairment loss | |||||
| Provision for deferred income taxes | |||||
| Loss on asset disposition | |||||
| Change in value of marketable securities | |||||
| Changes in operating assets and liabilities (net of the effect of acquisitions): | |||||
| Accounts and notes receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Operating leases | |||||
| Customer deposits | |||||
| Payroll and payroll tax liabilities | |||||
| Sales taxes payable | |||||
| Other | |||||
| Net cash and cash equivalents (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Purchase of property and equipment | |||||
| Purchase of marketable securities | |||||
| Maturities of marketable securities | |||||
| Proceeds from disposals of assets | |||||
| Net cash and cash equivalents provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal payments on long-term debt | |||||
| Common stock withheld for employee payroll taxes | |||||
| Common stock repurchased | |||||
| Proceeds from the sales of common stock and exercise of warrants and options, net of expenses | |||||
| Net cash and cash equivalents used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental Information: | |||||
| Right-of-use assets obtained in exchange for new or modified operating lease liabilities | |||||
| Fair value of common stock issued in business combination | |||||
| Fair value of contingent consideration | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash repurchase of liability awards | |||||
| Non-cash issuance of a note receivable | |||||
| Liability redemption associated with business acquisition | |||||
| Indemnity holdback from business acquisition | |||||
| Common stock issued for business combinations | |||||
| Common stock issued for intangible assets | |||||
Loading...